© 2021 MJH Life Sciences and HCPLive - Clinical news for connected physicians. All rights reserved.
© 2021 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
February 15, 2021
Researchers find higher neurocognitive abilities are associated with an improvement of everyday life.
February 11, 2021
February 04, 2021
A higher percentage of patients suffering from a severe mental disorder such as schizophrenia or bipolar disorder, died from a COVID-19 infection than the control group.
January 27, 2021
Individuals diagnosed with mood or anxiety disorders were not linked to higher COVID-19 mortality.
December 09, 2020
Experts expect more individuals to face mental health challenges caused by the events of 2020.
December 01, 2020
Repeated Transcranial Magnetic Stimulation shows more efficacy treating bipolar disorder than schizophrenia.
November 23, 2020
The lipid profile changes were not significant after 6 months, while the changes in the lipid profile are due to other factors and not the drugs.
November 19, 2020
The first-line atypical antipsychotic was linked to better outcomes in patients than comparators aripiprazole and olanzapine.
November 17, 2020
The agency did not find any efficacy or safety issues regarding the potential treatment for adults with schizophrenia or bipolar I disorder.
October 09, 2020
The schizophrenia drug currently has a PDUFA date set for November 15.